G01N 2333/5751
Corticotropin releasing factor [crf]
Official title: Corticotropin releasing factor [CRF] (Urotensin)
G01N2333/5751 (Corticotropin releasing factor [crf]) appears on 16 US grants and 15 published applications in this corpus.
Search patents in G01N- Granted patents
- 16
- Published applications
- 15
- Assignees
- 12
- Inventors
- 38
- Latest grant
- 17 May 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 4 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 3 | 2 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Agonists and antagonists of the urotensinergic system17 May 2016US 9,340,575 B2Institut National De La Recherche Scientifique
- Promoter sequences for corticotropin releasing-factor receptor CRF2α and method of identifying agents that alter the activity of the promoter sequences12 May 2009US 7,531,356 B2Wisconsin Alumni Research Foundation
- Method for identifying compounds for treating aging processes in the coronary circulatory system25 Mar 2008US 7,348,155 B2Sanofi-Aventis Deutschland GmbH
- Promoter sequences for corticotropin releasing-factor receptor CRF2α and method of identifying agents that alter the activity of the promoter sequences4 Jul 2006US 7,071,323 B2Wisconsin Alumni Research Foundation
- Substituted aryl 1, 4-pyrazine derivatives9 May 2006US 7,041,672 B2Pfizer Inc.
- Rapid polymerization of polyphenols16 Sep 2021US 2021/0285974 A1
- Methods for determining whether a patient is likely to benefit from treatment with a therapeutic formulation15 Aug 2019US 2019/0250173 A1Iconic Intellectual Property Limited
- Urine-based immuncassay for urocirtub 3 abd duagbisus if skeeo aobea9 Jun 2016US 2016/0161489 A1
- Novel agonists and antagonists of the urotensinergic system24 Apr 2014US 2014/0113872 A1Institut National De La Recherche Scientifique
- Assays26 Mar 2009US 2009/0081714 A1Inverness Medical Switzerland GmbH
Most cited
By later US patents
- Substituted aryl 1,4-pyrazine derivatives61US 6,992,087 B2Pfizer Inc. · 2006
- Substituted aryl 1, 4-pyrazine derivatives56US 7,041,672 B2Pfizer Inc. · 2006
- Method and means for the early detection and diagnosis of certain types of cancers29US 4,150,149 AProfessional Staff Association of the Los Angeles County Harbor General Hospital · 1979
- Cyclic CRF agonists24US 5,824,771 AThe Salk Institute for Biological Studies · 1998
- Cyclic CRF agonists15US 5,844,074 AThe Salk Institute for Biological Studies · 1998